非小细胞肺癌的管理:最近的发展
Martin Reck1, David F Heigener, Tony Mok
1LungenClinic Grosshansdorf, Airway Research Center North, Grosshansdorf, Germany. m.reck@lungenclinic.de
Lancet (London, England)
|August 27, 2013
概括
非小细胞肺癌 (NSCLC) 治疗正在向个性化医学发展. 本综述涵盖了诊断,手术和放射治疗策略以及针对NSCLC患者的向治疗的进展.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 医学诊断 医学诊断 医学诊断
背景情况:
- 非小细胞肺癌 (NSCLC) 仍然是全球癌症死亡的主要原因.
- 迫切需要在NSCLC管理中改进诊断和治疗策略.
- 当前的治疗模式需要向个性化方法进化.
研究的目的:
- 审查肺癌发展阶段的进展,以减少侵入性方法.
- 讨论开发适应NSCLC阶段的治疗方法.
- 突出NSCLC治疗的进展,包括向治疗和个性化医疗.
主要方法:
- 关于肺癌分期和治疗演变的当前文献的综述.
- 强调基于内镜和基于图像的诊断进步.
- 对新的外科手术,放射治疗和向治疗策略的分析.
主要成果:
- 肺癌分期正在转向非侵入性,基于内镜和基于图像的技术.
- 正在开发适应阶段的治疗方法,包括用于早期阶段的新型手术和放射治疗方法.
- 多模式治疗和向疗法对晚期和转移性NSCLC有前途.
结论:
- 肺癌治疗越来越个性化,专注于个体瘤特征.
- 诊断和治疗方面的进步对于改善NSCLC的结果至关重要.
- 针对性治疗的整合标志着迈向个性化肺癌护理的重要一步.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

